Robeco Institutional Asset Management B.V. reduced its stake in Xylem Inc (NYSE:XYL) by 38.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,560 shares of the industrial products company’s stock after selling 13,381 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Xylem were worth $1,439,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. CWM LLC boosted its holdings in shares of Xylem by 100.9% in the fourth quarter. CWM LLC now owns 681 shares of the industrial products company’s stock worth $45,000 after acquiring an additional 342 shares during the period. Meeder Asset Management Inc. boosted its holdings in shares of Xylem by 5,057.1% in the fourth quarter. Meeder Asset Management Inc. now owns 722 shares of the industrial products company’s stock worth $48,000 after acquiring an additional 708 shares during the period. Essex Savings Bank bought a new position in shares of Xylem in the fourth quarter worth $53,000. Mercer Capital Advisers Inc. boosted its holdings in shares of Xylem by 33.3% in the fourth quarter. Mercer Capital Advisers Inc. now owns 1,000 shares of the industrial products company’s stock worth $67,000 after acquiring an additional 250 shares during the period. Finally, Cascade Investment Advisors Inc. boosted its holdings in shares of Xylem by 25.0% in the fourth quarter. Cascade Investment Advisors Inc. now owns 1,000 shares of the industrial products company’s stock worth $67,000 after acquiring an additional 200 shares during the period. 84.01% of the stock is owned by hedge funds and other institutional investors.
NYSE:XYL opened at $75.85 on Thursday. The firm has a market cap of $13.76 billion, a P/E ratio of 26.34, a price-to-earnings-growth ratio of 1.29 and a beta of 1.21. Xylem Inc has a 52-week low of $60.65 and a 52-week high of $82.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.51 and a quick ratio of 1.08.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 14th. Investors of record on Thursday, February 14th will be paid a dividend of $0.24 per share. This is a positive change from Xylem’s previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, February 13th. This represents a $0.96 annualized dividend and a yield of 1.27%. Xylem’s dividend payout ratio (DPR) is currently 33.33%.
In other Xylem news, insider Tomas Brannemo sold 559 shares of Xylem stock in a transaction dated Thursday, February 21st. The stock was sold at an average price of $74.44, for a total transaction of $41,611.96. Following the completion of the sale, the insider now owns 10,568 shares of the company’s stock, valued at $786,681.92. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Kenneth Napolitano sold 35,526 shares of Xylem stock in a transaction dated Monday, February 4th. The stock was sold at an average price of $70.17, for a total value of $2,492,859.42. The disclosure for this sale can be found here. Insiders have sold 38,706 shares of company stock valued at $2,731,177 in the last three months. 0.81% of the stock is owned by corporate insiders.
A number of equities analysts have recently commented on XYL shares. Zacks Investment Research lowered Xylem from a “hold” rating to a “sell” rating in a report on Sunday, January 6th. Stifel Nicolaus raised Xylem from a “hold” rating to a “buy” rating and raised their price target for the stock from $72.00 to $75.00 in a report on Wednesday, December 19th. Boenning Scattergood reaffirmed a “buy” rating and issued a $82.00 price target on shares of Xylem in a report on Monday, November 19th. ValuEngine lowered Xylem from a “buy” rating to a “hold” rating in a report on Monday, February 4th. Finally, BMO Capital Markets reissued a “buy” rating and set a $85.00 price objective on shares of Xylem in a research note on Monday, February 25th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the stock. Xylem presently has an average rating of “Buy” and an average price target of $78.36.
TRADEMARK VIOLATION NOTICE: “Robeco Institutional Asset Management B.V. Has $1.44 Million Stake in Xylem Inc (XYL)” was posted by Markets Daily and is the property of of Markets Daily. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.themarketsdaily.com/2019/03/07/robeco-institutional-asset-management-b-v-has-1-44-million-stake-in-xylem-inc-xyl.html.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Read More: What is systematic risk?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.